SERP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.466000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.368200E-01
Normal-vs-Stage2
7.535400E-01
Normal-vs-Stage3
1.788850E-01
Normal-vs-Stage4
2.898800E-01
Stage1-vs-Stage2
9.320000E-01
Stage1-vs-Stage3
2.961600E-01
Stage1-vs-Stage4
4.525200E-01
Stage2-vs-Stage3
1.664200E-01
Stage2-vs-Stage4
3.310000E-01
Stage3-vs-Stage4
5.330100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.713400E-01
Normal-vs-AfricanAmerican
3.001000E-01
Normal-vs-Asian
8.531800E-01
Caucasian-vs-AfricanAmerican
3.000600E-01
Caucasian-vs-Asian
5.847000E-01
AfricanAmerican-vs-Asian
9.706300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.839800E-01
Normal-vs-Female
9.369000E-01
Male-vs-Female
3.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.953400E-01
Normal-vs-Age(41-60Yrs)
6.682600E-01
Normal-vs-Age(61-80Yrs)
8.970600E-01
Normal-vs-Age(81-100Yrs)
8.921600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.673800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.520600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.166200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.024600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.964600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.310800E-01
Normal-vs-Daily Drinker
5.469600E-01
Normal-vs-Weekly Drinker
5.365200E-01
Normal-vs-Occasional Drinker
5.757800E-01
Normal-vs-Social Drinker
8.693200E-01
Non Drinker-vs-Daily Drinker
1.469790E-01
Non Drinker-vs-Weekly Drinker
2.670000E-01
Non Drinker-vs-Occasional Drinker
2.459600E-01
Non Drinker-vs-Social Drinker
8.556000E-01
Daily Drinker-vs-Weekly Drinker
8.009800E-01
Daily Drinker-vs-Occasional Drinker
4.919800E-02
Daily Drinker-vs-Social Drinker
1.811600E-01
Weekly Drinker-vs-Occasional Drinker
6.577700E-02
Weekly Drinker-vs-Social Drinker
2.666400E-01
Occasional Drinker-vs-Social Drinker
3.695400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.498600E-01
Normal-vs-Grade 2
1.955750E-02
Normal-vs-Grade 3
1.247970E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.047800E-01
Grade 1-vs-Grade 3
3.256800E-01
Grade 1-vs-Grade 4
2.498600E-01
Grade 2-vs-Grade 3
7.284800E-01
Grade 2-vs-Grade 4
1.955750E-02
Grade 3-vs-Grade 4
1.247970E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.320800E-01
Normal-vs-NonDiabetic
9.846600E-01
Diabetic-vs-NonDiabetic
7.632400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.227800E-01
Normal-vs-NoPancreatitis
9.413800E-01
Pancreatitis-vs-NoPancreatitis
7.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.112600E-01
Normal-vs-N1
7.762800E-01
N0-vs-N1
4.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.910800E-01
Normal-vs-TP53-NonMutant
8.694400E-01
TP53-Mutant-vs-TP53-NonMutant
1.177230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
